Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian...
Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objective
It is unknown whether there are differences in efficacy and safety between quetiapine extended‐release, 300 mg/d (QUEXR300), and olanzapine, 5‐20 mg/d (OLA), for Japanese patients with bipolar depression.
Methods
We conducted a Bayesian analysis of data from phase 3 studies in Japan of QUEXR300 and OLA. Outcomes were remission ra...
Alternative Titles
Full title
Quetiapine extended‐release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_eba15cfdfd4e41768092a55c83bcec11
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eba15cfdfd4e41768092a55c83bcec11
Other Identifiers
ISSN
2574-173X
E-ISSN
2574-173X
DOI
10.1002/npr2.12070
